Prostate cancer diagnosis confirmed in a [Age] year-old male patient presenting with [Symptoms, e.g., lower urinary tract symptoms, erectile dysfunction, back pain].  Digital rectal examination revealed [DRE findings, e.g., an enlarged, firm, or nodular prostate].  Prostate-specific antigen (PSA) level measured [PSA value] ngmL.  Transrectal ultrasound (TRUS) guided biopsy of the prostate was performed, and histopathological analysis revealed [Gleason score] adenocarcinoma of the prostate.  Staging workup, including bone scan and CT scan of the abdomen and pelvis, was conducted to assess the extent of disease and determine appropriate prostate cancer treatment.  The TNM staging is currently [TNM stage].  Differential diagnoses considered included benign prostatic hyperplasia (BPH), prostatitis, and other urological conditions.  Treatment options discussed with the patient include active surveillance, radical prostatectomy, radiation therapy (external beam radiation therapy or brachytherapy), hormone therapy (androgen deprivation therapy), and chemotherapy.  Patient education regarding prostate cancer prognosis, side effects of treatment, and follow-up care was provided.  Referral to urology and oncology for further management and shared decision-making regarding prostate cancer treatment plan.  Medical coding will utilize ICD-10 code C61 for malignant neoplasm of the prostate and relevant CPT codes for procedures performed, including biopsy, imaging, and consultations.  This documentation supports medical billing for services rendered. The patient will continue to be monitored for prostate cancer recurrence and treatment-related complications.